AI assistant
CONMED Corp — Director's Dealing 2018
Mar 5, 2018
31971_dirs_2018-03-05_5ee2f43a-dfaa-4da6-a691-0c794e7dc26c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2018-03-01
Reporting Person: POMILIO LUKE A (Advisor to CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | Common Stock | M | 600 | — | Acquired | 600 | Direct |
| 2018-03-01 | Common Stock | F | 252 | $59.96 | Disposed | 348 | Direct |
| 2018-03-01 | Common Stock | M | 650 | — | Acquired | 998 | Direct |
| 2018-03-01 | Common Stock | F | 273 | $59.96 | Disposed | 725 | Direct |
| 2018-03-01 | Common Stock | M | 10020 | $39.87 | Acquired | 10745 | Direct |
| 2018-03-01 | Common Stock | S | 10020 | $60.1959 | Disposed | 725 | Direct |
| 2018-03-01 | Common Stock | M | 9600 | $41.93 | Acquired | 10325 | Direct |
| 2018-03-01 | Common Stock | S | 9600 | $60.1886 | Disposed | 725 | Direct |
| 2018-03-02 | Common Stock | S | 725 | $60.00 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-01 | Rsus (restricted Stock Units) | $0 | M | 600 | Disposed | 2025-02-27 | Common Stock (600) | Direct |
| 2018-03-01 | Rsus (restricted Stock Units) | $0 | M | 650 | Disposed | 2026-03-01 | Common Stock (650) | Direct |
| 2018-03-01 | Options To Purchase Common Stock | $39.87 | M | 10020 | Disposed | 2026-03-01 | Common Stock (10020) | Direct |
| 2018-03-01 | Options To Purchase Common Stock | $41.93 | M | 9600 | Disposed | 2027-03-01 | Common Stock (9600) | Direct |
Footnotes
F1: Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F3: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
F4: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period